Back to results
US 2015/0307865 A1Published application
Coagulation factor vii polypeptides
OwnerHenning R. Stennicke, Ole Hvilsted Olsen +1inventors
InventorsHenning R. Stennicke, Ole Hvilsted Olsen, Henrik Oestergaard
Life of this patent
Estimating the term…
Abstract
The present invention relates to modified coagulation Factor VII (Factor VII) polypeptides having coagulant activity as well as polynucleotide constructs encoding such polypeptides, vectors and host cells comprising and expressing such polynucleotides, pharmaceutical compositions, uses and methods of treatment.
Claims16
A Factor VII(a) polypeptide comprising two or more substitutions relative to the amino acid sequence of human Factor VII (SEQ ID NO:1),
- wherein at least one of the substitutions is where T293 has been replaced by Lys (K), Tyr (Y), Arg (R) or Phe (F);
- where Q176 has been replaced by Lys (K), Arg (R), Asn (N);
- and/or Q286 has been replaced by Asn (N) and
- wherein at least one of the substitutions is where M298 has been replaced by Gln (Q), Lys (K), Arg (R), Asn (N), Gly (G), Pro (P), Ala (A), Val (V), Leu (L), Ile (I), Phe (F), Trp (W), Tyr (Y), Asp (D), Glu (E), His (H), Cys (C), Ser (S), or Thr (T).
1 more element
(canceled)
(canceled)
Dependencies are inferred from the claim text.